Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.

Fulgent Genetics enters this update cycle with no changes to its price targets, leaving the existing analyst expectations intact for now. Even without new signals on where analysts think the stock could head next, you can still track what this steady stance might mean for your own view of the company. Read on to see how to keep up with the evolving narrative around Fulgent Genetics and where to look as fresh information comes through.

Stay updated as the Fair Value for Fulgent Genetics shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Fulgent Genetics.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives!

We’ve flagged 1 risk for Fulgent Genetics. See which could impact your investment.

How This Changes the Fair Value For Fulgent Genetics

• Fair value estimate unchanged, with no new valuation adjustments reported.

• Revenue growth assumptions unchanged, with no updates reported.

• Net profit margin assumptions unchanged, with no updates reported.

• P/E ratio input unchanged, with no updates reported.

• Discount rate assumptions unchanged, with no updates reported.

Never Miss an Update: Follow The Narrative

Narratives link a company’s story to a financial forecast and fair value, so you can see how key events might shape the outlook over time. They update automatically when new data or news is added, giving you a clear, structured view of what has changed and why.

Head over to the Simply Wall St Community and follow the Narrative on Fulgent Genetics to stay up to date on:

• How new contracts, partnerships, or product launches could influence future revenue expectations.

• Operational choices such as cost management, investment in new capabilities, or shifts in business focus that may affect profitability assumptions.

• Key risks around regulation, competitive pressures, or execution that could challenge the current outlook or introduce uncertainty into forecasts.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.